We are live on ! Find out more
EP

Elkhorn Partners Portfolio holdings

AUM $157M
1-Year Est. Return 11.91%
This Fund
S&P 500
This Quarter Est. Return
-4.18%
1 Year Est. Return
+11.91%
3 Year Est. Return
+31.51%
5 Year Est. Return
+35.62%
10 Year Est. Return
+87.18%
AUM
$144M
AUM Growth
-$8.38M
Cap. Flow
-$584K
Cap. Flow %
-0.4%
Top 10 Hldgs %
95.89%
Holding
54
New
3
Increased
9
Reduced
27
Closed
6

Sector Composition

Rank Sector Weight
1 Financials 52.35%
2 Real Estate 36.72%
3 Communication Services 4.28%
4 Technology 2%
5 Materials 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEPH icon
26
Nephros
NEPH
$38M
$110K 0.08%
31,900
-13,441
-30% -$29.3K
BAC icon
27
Bank of America
BAC
$439B
$104K 0.07%
3,100
-500
-14% -$14.6K
OXY icon
28
Occidental Petroleum
OXY
$53.6B
$103K 0.07%
+1,720
New +$105K
AMN icon
29
AMN Healthcare
AMN
$1.35B
$101K 0.07%
1,350
+800
+145% +$57.2K
CRDF icon
30
Cardiff Oncology
CRDF
$63.6M
$97K 0.07%
65,500
+20,500
+46% +$24.8K
JBLU icon
31
JetBlue
JBLU
$2.23B
$90K 0.06%
16,200
RDI icon
32
Reading International Class A
RDI
$33.2M
$81K 0.06%
42,500
PARA
33
DELISTED
Paramount Global Class B
PARA
$74K 0.05%
5,000
-10,900
-69% -$146K
MAX icon
34
MediaAlpha
MAX
$746M
$66K 0.05%
5,900
-9,600
-62% -$95K
UAL icon
35
United Airlines
UAL
$40.2B
$65K 0.05%
1,580
-30
-2% -$1.18K
XOM icon
36
ExxonMobil
XOM
$634B
$60K 0.04%
+605
New +$63.6K
KMI icon
37
Kinder Morgan
KMI
$70.3B
$56K 0.04%
3,200
-2,000
-38% -$34.1K
MRNA icon
38
Moderna
MRNA
$22.1B
$55K 0.04%
550
-630
-53% -$53K
VXX icon
39
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$159M
$54K 0.04%
875
FPH icon
40
Five Point Holdings
FPH
$395M
$52K 0.04%
17,000
HTZ icon
41
Hertz
HTZ
$556M
$52K 0.04%
5,000
+1,000
+25% +$9.66K
NWLI
42
DELISTED
National Western Life Group, Inc. Class A
NWLI
$46K 0.03%
95
-45
-32% -$21.4K
GILD icon
43
Gilead Sciences
GILD
$167B
$28K 0.02%
350
-550
-61% -$42.8K
CVX icon
44
Chevron
CVX
$374B
$27K 0.02%
+180
New +$27.2K
SCHW
45
Charles Schwab
SCHW
$184B
$14K 0.01%
200
-350
-64% -$20.2K
NDAQ icon
46
Nasdaq
NDAQ
$53.6B
$6K ﹤0.01%
100
-875
-90% -$46.1K
NVDA icon
47
NVIDIA
NVDA
$4.77T
$1K ﹤0.01%
30
-190
-86% -$8.8K
AMZN icon
48
Amazon
AMZN
$2.48T
-40
Closed -$5K
CREX icon
49
Creative Realities
CREX
$41.4M
$0 ﹤0.01%
26
CRSP icon
50
CRISPR Therapeutics
CRSP
$4.68B
-250
Closed -$11K

Similar funds

Elkhorn Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Elkhorn Partners held 54 positions worth $144M, down 5.5% from $153M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Elkhorn Partners's Q4 2023 filing shows 3 new, 9 increased, 27 reduced and 6 closed positions. Its largest new stake was Occidental Petroleum: 1,720 shares worth $103K. The largest sale was PolyMet Mining Corp., an estimated $586K.

By sector, the portfolio is most concentrated in Financials at 52% of assets, up from 49% a quarter earlier, followed by Real Estate and Communication Services.

  • Elkhorn Partners's largest Q4 2023 buy was Occidental Petroleum: 1,720 shares worth $103K.
  • Elkhorn Partners added most to Kennedy-Wilson Holdings in Q4 2023, an estimated $633K increase.
  • Elkhorn Partners's biggest Q4 2023 reduction was Cleveland-Cliffs, cutting an estimated $149K.
  • Elkhorn Partners fully exited PolyMet Mining Corp. in Q4 2023, selling an estimated $586K.
  • Elkhorn Partners's ten largest holdings make up 96% of its $144M portfolio in Q4 2023.
  • Elkhorn Partners opened 3 new positions and closed 6 in Q4 2023.
  • Elkhorn Partners's portfolio value fell 5.5% quarter-over-quarter to $144M.

Based on Elkhorn Partners's 13F filing for Q4 2023, filed 13 Feb 2024.